 | • レポートコード：MRC309Z7867 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の糖質コルチコイドの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の糖質コルチコイド市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 糖質コルチコイドの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 糖質コルチコイド市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・コルチゾン、プレドニゾン、プレドニゾロン、メチルプレドニゾロン、デキサメタゾン、ベタメタゾン、ヒドロコルチゾン、その他 用途別セグメント ・抗炎症作用、免疫抑制作用、血管収縮作用 主要な市場プレーヤー ・Pfizer、Novartis、Aspen、Euroapi、Sanofi、Avik Pharmaceutical Limited、Symbiotec、Cipla、Abbott Laboratories、Tianjin Tianyao Pharmaceuticals Co., Ltd.、Zhejiang Xianju Pharmaceutical Co.,Ltd、Shandong Xinhua Pharmaceutical Company Limited、Yangzi River Pharmaceutical Group 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、糖質コルチコイド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な糖質コルチコイドメーカーの企業概要、2019年～2022年までの糖質コルチコイドの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な糖質コルチコイドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別糖質コルチコイドの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの糖質コルチコイドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での糖質コルチコイド市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および糖質コルチコイドの産業チェーンを掲載しています。 ・第14、15章では、糖質コルチコイドの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 糖質コルチコイドの概要 - 種類別分析（2018年vs2022年vs2029年）：コルチゾン、プレドニゾン、プレドニゾロン、メチルプレドニゾロン、デキサメタゾン、ベタメタゾン、ヒドロコルチゾン、その他 - 用途別分析（2018年vs2022年vs2029年）：抗炎症作用、免疫抑制作用、血管収縮作用 - 世界の糖質コルチコイド市場規模・予測 - 世界の糖質コルチコイド生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Novartis、Aspen、Euroapi、Sanofi、Avik Pharmaceutical Limited、Symbiotec、Cipla、Abbott Laboratories、Tianjin Tianyao Pharmaceuticals Co., Ltd.、Zhejiang Xianju Pharmaceutical Co.,Ltd、Shandong Xinhua Pharmaceutical Company Limited、Yangzi River Pharmaceutical Group ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：コルチゾン、プレドニゾン、プレドニゾロン、メチルプレドニゾロン、デキサメタゾン、ベタメタゾン、ヒドロコルチゾン、その他 ・用途別分析2018年-2029年：抗炎症作用、免疫抑制作用、血管収縮作用 ・糖質コルチコイドの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・糖質コルチコイドのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・糖質コルチコイドのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・糖質コルチコイドの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・糖質コルチコイドの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Glucocorticoids market size was valued at USD 4990.4 million in 2022 and is forecast to a readjusted size of USD 6833.9 million by 2029 with a CAGR of 4.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Glucocorticoids are given in relatively large doses for the treatment and prevention of cerebral edema in patients with brain tumors and in some patients with bacterial meningitis.
This report is a detailed and comprehensive analysis for global Glucocorticoids market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Glucocorticoids market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Glucocorticoids market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Glucocorticoids market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Glucocorticoids market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucocorticoids
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucocorticoids market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Aspen, Euroapi and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Glucocorticoids market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cortisone
Prednisone
Prednisolone
Methylprednisolone
Dexamethasone
Betamethasone
Hydrocortisone
Others
Market segment by Application
Anti-inflammatory
Immunosuppressive
Vasoconstrictive
Major players covered
Pfizer
Novartis
Aspen
Euroapi
Sanofi
Avik Pharmaceutical Limited
Symbiotec
Cipla
Abbott Laboratories
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucocorticoids product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucocorticoids, with price, sales, revenue and global market share of Glucocorticoids from 2018 to 2023.
Chapter 3, the Glucocorticoids competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucocorticoids breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Glucocorticoids market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucocorticoids.
Chapter 14 and 15, to describe Glucocorticoids sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Glucocorticoids
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glucocorticoids Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Cortisone
1.3.3 Prednisone
1.3.4 Prednisolone
1.3.5 Methylprednisolone
1.3.6 Dexamethasone
1.3.7 Betamethasone
1.3.8 Hydrocortisone
1.3.9 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Glucocorticoids Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anti-inflammatory
1.4.3 Immunosuppressive
1.4.4 Vasoconstrictive
1.5 Global Glucocorticoids Market Size & Forecast
1.5.1 Global Glucocorticoids Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Glucocorticoids Sales Quantity (2018-2029)
1.5.3 Global Glucocorticoids Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Glucocorticoids Product and Services
2.1.4 Pfizer Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Glucocorticoids Product and Services
2.2.4 Novartis Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments/Updates
2.3 Aspen
2.3.1 Aspen Details
2.3.2 Aspen Major Business
2.3.3 Aspen Glucocorticoids Product and Services
2.3.4 Aspen Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aspen Recent Developments/Updates
2.4 Euroapi
2.4.1 Euroapi Details
2.4.2 Euroapi Major Business
2.4.3 Euroapi Glucocorticoids Product and Services
2.4.4 Euroapi Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Euroapi Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Glucocorticoids Product and Services
2.5.4 Sanofi Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Avik Pharmaceutical Limited
2.6.1 Avik Pharmaceutical Limited Details
2.6.2 Avik Pharmaceutical Limited Major Business
2.6.3 Avik Pharmaceutical Limited Glucocorticoids Product and Services
2.6.4 Avik Pharmaceutical Limited Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Avik Pharmaceutical Limited Recent Developments/Updates
2.7 Symbiotec
2.7.1 Symbiotec Details
2.7.2 Symbiotec Major Business
2.7.3 Symbiotec Glucocorticoids Product and Services
2.7.4 Symbiotec Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Symbiotec Recent Developments/Updates
2.8 Cipla
2.8.1 Cipla Details
2.8.2 Cipla Major Business
2.8.3 Cipla Glucocorticoids Product and Services
2.8.4 Cipla Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cipla Recent Developments/Updates
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business
2.9.3 Abbott Laboratories Glucocorticoids Product and Services
2.9.4 Abbott Laboratories Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Abbott Laboratories Recent Developments/Updates
2.10 Tianjin Tianyao Pharmaceuticals Co., Ltd.
2.10.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Details
2.10.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Major Business
2.10.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product and Services
2.10.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
2.11 Zhejiang Xianju Pharmaceutical Co.,Ltd
2.11.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
2.11.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
2.11.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product and Services
2.11.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
2.12 Shandong Xinhua Pharmaceutical Company Limited
2.12.1 Shandong Xinhua Pharmaceutical Company Limited Details
2.12.2 Shandong Xinhua Pharmaceutical Company Limited Major Business
2.12.3 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product and Services
2.12.4 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
2.13 Yangzi River Pharmaceutical Group
2.13.1 Yangzi River Pharmaceutical Group Details
2.13.2 Yangzi River Pharmaceutical Group Major Business
2.13.3 Yangzi River Pharmaceutical Group Glucocorticoids Product and Services
2.13.4 Yangzi River Pharmaceutical Group Glucocorticoids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Glucocorticoids by Manufacturer
3.1 Global Glucocorticoids Sales Quantity by Manufacturer (2018-2023)
3.2 Global Glucocorticoids Revenue by Manufacturer (2018-2023)
3.3 Global Glucocorticoids Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Glucocorticoids by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Glucocorticoids Manufacturer Market Share in 2022
3.4.2 Top 6 Glucocorticoids Manufacturer Market Share in 2022
3.5 Glucocorticoids Market: Overall Company Footprint Analysis
3.5.1 Glucocorticoids Market: Region Footprint
3.5.2 Glucocorticoids Market: Company Product Type Footprint
3.5.3 Glucocorticoids Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Glucocorticoids Market Size by Region
4.1.1 Global Glucocorticoids Sales Quantity by Region (2018-2029)
4.1.2 Global Glucocorticoids Consumption Value by Region (2018-2029)
4.1.3 Global Glucocorticoids Average Price by Region (2018-2029)
4.2 North America Glucocorticoids Consumption Value (2018-2029)
4.3 Europe Glucocorticoids Consumption Value (2018-2029)
4.4 Asia-Pacific Glucocorticoids Consumption Value (2018-2029)
4.5 South America Glucocorticoids Consumption Value (2018-2029)
4.6 Middle East and Africa Glucocorticoids Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Glucocorticoids Sales Quantity by Type (2018-2029)
5.2 Global Glucocorticoids Consumption Value by Type (2018-2029)
5.3 Global Glucocorticoids Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Glucocorticoids Sales Quantity by Application (2018-2029)
6.2 Global Glucocorticoids Consumption Value by Application (2018-2029)
6.3 Global Glucocorticoids Average Price by Application (2018-2029)
7 North America
7.1 North America Glucocorticoids Sales Quantity by Type (2018-2029)
7.2 North America Glucocorticoids Sales Quantity by Application (2018-2029)
7.3 North America Glucocorticoids Market Size by Country
7.3.1 North America Glucocorticoids Sales Quantity by Country (2018-2029)
7.3.2 North America Glucocorticoids Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Glucocorticoids Sales Quantity by Type (2018-2029)
8.2 Europe Glucocorticoids Sales Quantity by Application (2018-2029)
8.3 Europe Glucocorticoids Market Size by Country
8.3.1 Europe Glucocorticoids Sales Quantity by Country (2018-2029)
8.3.2 Europe Glucocorticoids Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Glucocorticoids Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Glucocorticoids Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Glucocorticoids Market Size by Region
9.3.1 Asia-Pacific Glucocorticoids Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Glucocorticoids Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Glucocorticoids Sales Quantity by Type (2018-2029)
10.2 South America Glucocorticoids Sales Quantity by Application (2018-2029)
10.3 South America Glucocorticoids Market Size by Country
10.3.1 South America Glucocorticoids Sales Quantity by Country (2018-2029)
10.3.2 South America Glucocorticoids Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Glucocorticoids Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Glucocorticoids Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Glucocorticoids Market Size by Country
11.3.1 Middle East & Africa Glucocorticoids Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Glucocorticoids Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Glucocorticoids Market Drivers
12.2 Glucocorticoids Market Restraints
12.3 Glucocorticoids Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Glucocorticoids and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glucocorticoids
13.3 Glucocorticoids Production Process
13.4 Glucocorticoids Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glucocorticoids Typical Distributors
14.3 Glucocorticoids Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer